Association of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yuasa, Daisuke ^a   Ohashi, Koji ^a   Shibata, Rei ^a   Takeshita, Kyosuke ^a   Kikuchi, Ryosuke ^a   Takahashi, Ryotaro ^b   Kataoka, Yoshiyuki ^a   Miyabe, Megumi ^a   Joki, Yusuke ^a   Kambara, Takahiro ^a   Uemura, Yusuke ^a   Matsuo, Kazuhiro ^a   Hayakawa, Satoko ^a   Hiramatsu Ito, Mizuho ^a   Ito, Masanori ^a   Ikeda, Nobuo ^b   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chunichi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q TUMOR NECROSIS FACTOR RELATED PROTEIN; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; C1QTNF1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTEINS; TRIGLYCERIDES;

EID: 84903384872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099846     Document Type: Article

References (24)

1. Friedman JM (2003) A war on obesity, not the obese. Science 299: 856-858.
2. Matsuzawa Y (2006) Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3: 35-42.
3. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
4. Long Y, Gracely EJ, Newschaffer CJ, Liu L (2013) Analysis of the prevalence of cardiovascular disease and associated risk factors for European-American and African-American populations in the state of Pennsylvania 2005-2009. Am J Cardiol 111: 68-72.
5. Kastorini CM, Georgousopoulou E, Vemmos KN, Nikolaou V, Kantas D, et al. (2013) Comparative analysis of cardiovascular disease risk factors influencing nonfatal acute coronary syndrome and ischemic stroke. Am J Cardiol 112: 349-354.
6. Liu L, Miura K, Fujiyoshi A, Kadota A, Miyagawa N, et al. (2014) Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan. Am J Cardiol 113: 84-89.
7. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
8. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91. (Pubitemid 23036092)
9. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289. (Pubitemid 26136463)
10. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14: 561-566. (Pubitemid 41623184)
11. Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, et al. (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329: 454-457.
12. Enomoto T, Ohashi K, Shibata R, Higuchi A, Maruyama S, et al. (2011) Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem 286: 34552-34558.
13. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, et al. (2011) Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219: 811-814.
14. Shibata R, Ouchi N, Takahashi R, Terakura Y, Ohashi K, et al. (2012) Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr 4: 37.
15. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF (2004) A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 101: 10302-10307. (Pubitemid 38924920)
16. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, et al. (2008) Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 416: 161-177.
17. Kim KY, Kim HY, Kim JH, Lee CH, Kim DH, et al. (2006) Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 580: 3953-3960. (Pubitemid 43946893)
18. Peterson JM, Aja S, Wei Z, Wong GW (2012) CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem 287: 1576-1587.
19. Chalupova L, Zakovska A, Adamcova K (2013) Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem 46: 73-78.
20. Jeon JH, Kim KY, Kim JH, Baek A, Cho H, et al. (2008) A novel adipokine CTRP1 stimulates aldosterone production. FASEB J 22: 1502-1511. (Pubitemid 351656790)
21. Lasser G, Guchhait P, Ellsworth JL, Sheppard P, Lewis K, et al. (2006) C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood 107: 423-430. (Pubitemid 43076360)
22. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
23. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
24. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83. (Pubitemid 29299050)